Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns

Date:




The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Record March heat possible again & still dry

NEW MEXICO (KRQE) - Slightly milder air has started...

Temu Owner PDD Posts Surprise Profit Drop

The Chinese owner of shopping app Temu reported lower...

Turnovers and luck: Which 2026 college football teams improve

Bill ConnellyMar 24, 2026, 06:47 AM ETCloseBill Connelly is...